Literature DB >> 15276609

The Toll of herpes simplex virus infection.

Lynda A Morrison1.   

Abstract

Herpes simplex virus (HSV) infections provoke an inflammatory cytokine response, but the innate pathogen-sensing mechanisms that transduce the signal for this response are poorly understood. Recent findings have revealed that Toll-like receptor (TLR) 2 initiates the inflammatory process, and surprisingly that the response the TLR triggers might be overzealous in its attempt to counter the attack by the virus. Other recent findings suggest complexity in the array of TLRs that are triggered by HSV and the cell types they activate. Here we discuss the new revelations about these guardians against HSV infection and the consequences of the alarms raised in the host that they are assigned to protect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276609     DOI: 10.1016/j.tim.2004.06.001

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  16 in total

1.  Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro.

Authors:  Yuan-Jin Guo; Tao Luo; Fei Wu; Huan Liu; Hua-Rong Li; Yuan-Wu Mei; Shu-Ling Zhang; Jun-Yan Tao; Ji-Hua Dong; Yuan Fang; Lei Zhao
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 2.  Sexual dimorphism in innate immune responses to infectious organisms.

Authors:  Ian Marriott; Yvette M Huet-Hudson
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Linkage mapping of toll-like receptors (TLRs) in Japanese flounder, Paralichthys olivaceus.

Authors:  Seong Don Hwang; Kanako Fuji; Tomokazu Takano; Takashi Sakamoto; Hidehiro Kondo; Ikuo Hirono; Takashi Aoki
Journal:  Mar Biotechnol (NY)       Date:  2011-04-15       Impact factor: 3.619

4.  Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response.

Authors:  Seungmin Hwang; Kyeong Seon Kim; Emilio Flano; Ting-Ting Wu; Leming M Tong; Ann N Park; Moon Jung Song; David Jesse Sanchez; Ryan M O'Connell; Genhong Cheng; Ren Sun
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

Review 5.  Herpesviral infection and Toll-like receptor 2.

Authors:  Ming-sheng Cai; Mei-li Li; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-08-04       Impact factor: 14.870

6.  Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes.

Authors:  David M Koelle; Jay Huang; Michael T Hensel; Christopher L McClurkan
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 7.  Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy.

Authors:  Chris L McGowin; Richard B Pyles
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

8.  Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.

Authors:  Zhiwei Yin; Jihong Dai; Jing Deng; Faruk Sheikh; Mahwish Natalia; Tiffany Shih; Anita Lewis-Antes; Sheela B Amrute; Ursula Garrigues; Sean Doyle; Raymond P Donnelly; Sergei V Kotenko; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2012-08-13       Impact factor: 5.422

9.  Identification of a novel pathway essential for the immediate-early, interferon-independent antiviral response to enveloped virions.

Authors:  Ryan S Noyce; Susan E Collins; Karen L Mossman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

10.  A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.

Authors:  Zane Zeier; J Santiago Aguilar; Cecilia M Lopez; G B Devi-Rao; Zachary L Watson; Henry V Baker; Edward K Wagner; David C Bloom
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.